Volume Replacement in Hypovolemic Shock
Use crystalloids as first-line fluid therapy for hypovolemic shock, specifically balanced crystalloids (such as Ringer's Lactate or Plasmalyte) rather than normal saline to reduce mortality and adverse renal events. 1
Fluid Selection Algorithm
First-Line: Crystalloids (Strongly Recommended)
- Balanced crystalloids are preferred over 0.9% normal saline as initial resuscitation fluid to reduce the risk of hyperchloremic metabolic acidosis and adverse kidney events, particularly when large volumes (>5000 mL) are anticipated 1, 2
- Isotonic saline remains acceptable but carries higher risk of hyperchloremia-associated complications with high-volume resuscitation 1
- For pediatric and neonatal populations, isotonic saline is specifically recommended as the first-choice fluid 1
Avoid Colloids in Most Situations
- Hydroxyethyl starches should be avoided entirely due to significantly increased risks of renal failure, coagulopathy, hemorrhage, and higher transfusion requirements without mortality benefit 1
- Albumin shows no mortality benefit in hemorrhagic shock and is not cost-effective (approximately 140 Euro/L vs 1.5 Euro/L for isotonic saline) 1, 2
- Gelatins demonstrate no superiority over crystalloids for mortality or renal outcomes 1
- The CRISTAL trial showed no 28-day mortality difference between colloids and crystalloids in hypovolemic shock, though 90-day mortality favored colloids (exploratory finding requiring further validation) 3
Administration Strategy
Initial Bolus Approach
- Administer 250-1000 mL rapid boluses for adults, reassessing hemodynamic status after each bolus 2
- For septic shock specifically, give at least 30 mL/kg crystalloid within the first 3 hours 2, 4, 5
- Pediatric dosing: up to 60 mL/kg for hypovolemic and septic shock 1
Reassessment Parameters After Each Bolus
Monitor these specific endpoints 2, 4:
- Heart rate and blood pressure trends
- Skin perfusion and capillary refill time
- Urine output (target >0.5 mL/kg/hr)
- Mental status improvement
- Serum lactate reduction (aim for 20% decrease if elevated)
- Dynamic measures of fluid responsiveness (preferred over static CVP measurements)
When to Stop Fluid Administration
Discontinue further boluses when 4:
- No improvement in tissue perfusion occurs despite additional fluid
- Signs of fluid overload develop (pulmonary crackles, increased JVP, worsening respiratory function)
- Hemodynamic parameters stabilize
Critical Pitfalls to Avoid
Volume Depletion Must Be Corrected First
- Blood volume depletion must always be corrected as fully as possible before administering vasopressors 6
- If vasopressors are required emergently to prevent cerebral or coronary ischemia, they can be given concurrently with ongoing volume replacement 6
- Occult hypovolemia should always be suspected if patients require escalating vasopressor doses 6
High-Volume Resuscitation Considerations
- In hemorrhagic shock requiring >5000-10,000 mL in 24 hours (common in trauma), balanced crystalloids show particular advantage over normal saline for reducing hyperchloremia-associated mortality 1
- Crystalloids require 2-4 times the volume of colloids to achieve similar hemodynamic endpoints, but this does not translate to worse outcomes 7
Special Population: Chronic Kidney Disease
- Use the same crystalloid-first approach but with heightened vigilance for fluid overload 4
- Consider earlier vasopressor initiation (norepinephrine first-line) if hypotension persists despite initial resuscitation, to limit excessive fluid accumulation 4
- Avoid hydroxyethyl starches particularly in this population due to compounded renal injury risk 4
Vasopressor Integration
When to Initiate
- Start norepinephrine if hypotension persists despite adequate fluid resuscitation 4, 5
- Target mean arterial pressure ≥65 mmHg 5
- Norepinephrine is the first-choice vasopressor; add epinephrine if additional agent needed 5